dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· December 9, 2025

Earnings live: AutoZone, Toll Brothers stocks fall, Campbell's sales decline

View original at finance.yahoo.com
Earnings live: AutoZone, Toll Brothers stocks fall, Campbell's sales decline Only a handful of major companies have yet to report their results for the last quarter, and AI leader Oracle (ORCL) is one of them…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • 306 S&P 500 companies mentioned AI on Q3 earnings calls, a record high in 10 years

    80% confidence
  • AI clusters now measured in hundreds of thousands of GPUs and soon millions

    80% confidence
  • Kroger facing tougher consumer and competitive environment from Amazon grocery push and Walmart grocery share gains

    80% confidence
  • Housing market is soft and choppy

    80% confidence
  • Many consumers' wallets are pressured and seeking value

    80% confidence
  • Consumers remain intentional in shopping behaviors

    80% confidence
  • Since Sept 30, AI-mentioning companies averaged +1% vs +0.3% for non-AI companies; since Dec 31 2024, AI-mentioning averaged +13.9% vs +5.7% non-AI

    80% confidence
  • Price increases from tariffs likely to persist for a couple more quarters before normalizing, and LIFO charges to normalize in FY'26 and recover in FY'27

    80% confidence
  • CrowdStrike is a second/third derivative beneficiary of AI Revolution

    80% confidence
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Sources réconciliées : aucun conflit ouvert pour l'instant.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,959
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,959 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Earnings live: AutoZone, Toll Brothers stocks fall, Campbell's sales decline: Source | Via News | fr.via.news